141 related articles for article (PubMed ID: 12663676)
21. Dissection of functional NF-Y-RFX cooperative interactions on the MHC class II Ea promoter.
Caretti G; Cocchiarella F; Sidoli C; Villard J; Peretti M; Reith W; Mantovani R
J Mol Biol; 2000 Sep; 302(3):539-52. PubMed ID: 10986117
[TBL] [Abstract][Full Text] [Related]
22. The RFX complex is crucial for the constitutive and CIITA-mediated transactivation of MHC class I and beta2-microglobulin genes.
Gobin SJ; Peijnenburg A; van Eggermond M; van Zutphen M; van den Berg R; van den Elsen PJ
Immunity; 1998 Oct; 9(4):531-41. PubMed ID: 9806639
[TBL] [Abstract][Full Text] [Related]
23. The bare lymphocyte syndrome and the regulation of MHC expression.
Reith W; Mach B
Annu Rev Immunol; 2001; 19():331-73. PubMed ID: 11244040
[TBL] [Abstract][Full Text] [Related]
24. Associations and interactions between bare lymphocyte syndrome factors.
DeSandro AM; Nagarajan UM; Boss JM
Mol Cell Biol; 2000 Sep; 20(17):6587-99. PubMed ID: 10938133
[TBL] [Abstract][Full Text] [Related]
25. New functions of the major histocompatibility complex class II-specific transcription factor RFXANK revealed by a high-resolution mutagenesis study.
Krawczyk M; Masternak K; Zufferey M; Barras E; Reith W
Mol Cell Biol; 2005 Oct; 25(19):8607-18. PubMed ID: 16166641
[TBL] [Abstract][Full Text] [Related]
26. [Research progress on regulation of class II MHC expression].
Sun QH; Peng JP
Sheng Li Ke Xue Jin Zhan; 2004 Jan; 35(1):25-9. PubMed ID: 15127593
[TBL] [Abstract][Full Text] [Related]
27. Conserved residues of the bare lymphocyte syndrome transcription factor RFXAP determine coordinate MHC class II expression.
Long AB; Ferguson AM; Majumder P; Nagarajan UM; Boss JM
Mol Immunol; 2006 Feb; 43(5):395-409. PubMed ID: 16337482
[TBL] [Abstract][Full Text] [Related]
28. Chromatin remodeling and extragenic transcription at the MHC class II locus control region.
Masternak K; Peyraud N; Krawczyk M; Barras E; Reith W
Nat Immunol; 2003 Feb; 4(2):132-7. PubMed ID: 12524537
[TBL] [Abstract][Full Text] [Related]
29. Assembly of the RFX complex on the MHCII promoter: role of RFXAP and RFXB in relieving autoinhibition of RFX5.
Garvie CW; Boss JM
Biochim Biophys Acta; 2008 Dec; 1779(12):797-804. PubMed ID: 18723135
[TBL] [Abstract][Full Text] [Related]
30. Multiple interactions between BRG1 and MHC class II promoter binding proteins.
Mudhasani R; Fontes JD
Mol Immunol; 2005 Apr; 42(6):673-82. PubMed ID: 15781111
[TBL] [Abstract][Full Text] [Related]
31. Interferon-gamma induces major histocompatibility class II transactivator (CIITA), which mediates collagen repression and major histocompatibility class II activation by human aortic smooth muscle cells.
Butticè G; Miller J; Wang L; Smith BD
Circ Res; 2006 Mar; 98(4):472-9. PubMed ID: 16439692
[TBL] [Abstract][Full Text] [Related]
32. The MHC class II transactivator (CIITA) requires conserved leucine charged domains for interactions with the conserved W box promoter element.
Brown JA; Rogers EM; Boss JM
Nucleic Acids Res; 1998 Sep; 26(18):4128-36. PubMed ID: 9722631
[TBL] [Abstract][Full Text] [Related]
33. Expression of RAB4B, a protein governing endocytic recycling, is co-regulated with MHC class II genes.
Krawczyk M; Leimgruber E; Seguín-Estévez Q; Dunand-Sauthier I; Barras E; Reith W
Nucleic Acids Res; 2007; 35(2):595-605. PubMed ID: 17175541
[TBL] [Abstract][Full Text] [Related]
34. Phosphorylation of CIITA directs its oligomerization, accumulation and increased activity on MHCII promoters.
Tosi G; Jabrane-Ferrat N; Peterlin BM
EMBO J; 2002 Oct; 21(20):5467-76. PubMed ID: 12374747
[TBL] [Abstract][Full Text] [Related]
35. IL-1 beta inhibits IFN-gamma-induced class II MHC expression by suppressing transcription of the class II transactivator gene.
Rohn W; Tang LP; Dong Y; Benveniste EN
J Immunol; 1999 Jan; 162(2):886-96. PubMed ID: 9916712
[TBL] [Abstract][Full Text] [Related]
36. Analysis of the defect in IFN-gamma induction of MHC class II genes in G1B cells: identification of a novel and functionally critical leucine-rich motif (62-LYLYLQL-68) in the regulatory factor X 5 transcription factor.
Brickey WJ; Wright KL; Zhu XS; Ting JP
J Immunol; 1999 Dec; 163(12):6622-30. PubMed ID: 10586057
[TBL] [Abstract][Full Text] [Related]
37. Combinations of dominant-negative class II transactivator, p300 or CDK9 proteins block the expression of MHC II genes.
Kanazawa S; Peterlin BM
Int Immunol; 2001 Jul; 13(7):951-8. PubMed ID: 11431425
[TBL] [Abstract][Full Text] [Related]
38. Direct genetic correction as a new method for diagnosis and molecular characterization of MHC class II deficiency.
Matheux F; Ikinciogullari A; Zapata DA; Barras E; Zufferey M; Dogu F; Regueiro JR; Reith W; Villard J
Mol Ther; 2002 Dec; 6(6):824-9. PubMed ID: 12498778
[TBL] [Abstract][Full Text] [Related]
39. HDAC2 deacetylates class II transactivator and suppresses its activity in macrophages and smooth muscle cells.
Kong X; Fang M; Li P; Fang F; Xu Y
J Mol Cell Cardiol; 2009 Mar; 46(3):292-9. PubMed ID: 19041327
[TBL] [Abstract][Full Text] [Related]
40. The S box of major histocompatibility complex class II promoters is a key determinant for recruitment of the transcriptional co-activator CIITA.
Muhlethaler-Mottet A; Krawczyk M; Masternak K; Spilianakis C; Kretsovali A; Papamatheakis J; Reith W
J Biol Chem; 2004 Sep; 279(39):40529-35. PubMed ID: 15271997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]